- 16h00 -16h10 Welcome and introduction
Pr Alfredo Addeo, M.D., Head, Division of Medical Oncology at HUG and Associate Professor of Oncology at University of Geneva - 16h10-16h40 : Biomarker to guide treatment decision in SCLC
Dr Claudio De Vito, Staff Physician, Division of Clinical pathology, HUG - 16h40 - 17h10 : The state of the art in LD-SCLC
Dr Maxime Borgeaud, M.D., Senior Resident, Medical Oncology, HUG - 17h10 - 17h40 : The role of surgery in SCLC, limited and extensive disease
Wolfram Karenovics, Lead, Head of Lung Cancer Center, Staff Physician, Division Thoracic Surgery, HUG - 17h40 - 18h00 : State of the art of 1st line in ED-SCLC
Dr Mountzios Giannis, Medical oncologist, Henry Dunant Hospital Center, Athens - 18h00 - 18h10 : State of the art of 2nd and beyond line in ED-SCLC
Dre Pecci Federica, Medical oncologist, Oncology Service , University of Parma, Italy - 18h10 – 18h30 Q&A and take home message
- 18h30 – 19h00 Aperitif
Hôpitaux universitaires de Genève
Symposium
Evénement professionnel
Experts perspectives and case discussions
Small Cell Lung Cancer is moving fast , are we keeping up? Join us for an interactive evening bringing together experts across pathology, surgery and medical oncology to discuss the latest advances in SCLC, from biomarkers and limited-stage disease to first-line and later-line treatment of extensive-stage disease. Expect practical insights, case-based discussion and plenty of opportunity for exchange with colleagues.
Whether you join us on site at HUG or online, don’t miss this opportunity to exchange with colleagues, earn CME credits, and enjoy a convivial aperitif to close the evening.
Program
Quick facts
Wednesday 25 November 2026 - HUG
16h00 - 19h00
On site & on line event
Auditoire Gustave Julliard, bâtiment Gustave Julliard, Etage 0, HUG
Rue Alcide-Jentzer 17, 1205 Genève
CME credits : GMO/SSOM, SRO/SSRO, SSP
Registration :
- On site
- On line : catherine.cretton@hug.ch